Navigation Links
ONCOLOGY and the Cancer Network Launch "Consultations in Ethics" Feature
Date:9/5/2012

NORWALK, Conn., Sept. 5, 2012 /PRNewswire/ -- Oncologists regularly struggle with difficult ethical issues in the course of daily practice. To help them respond more confidently to the ethical dilemmas they encounter, UBM Medica US has launched a new feature, "Consultations in Ethics," both in the journal ONCOLOGY and on the Cancer Network.

"Consultations in Ethics" presents actual cases submitted by oncologists, along with discussion of the ethical issues involved. The case reviews are provided by Dr. Paul R. Helft, director of the Charles Warren Fairbanks Center for Medical Ethics at Indiana University Health in Indianapolis and a member of ONCOLOGY's Editorial Board.

The inaugural cases and consultations include explorations of issues such as these:

  • A patient insists that you explore unproven alternative therapies for his metastatic colon cancer. Are you obliged to discuss these with him?
  • How should you treat a squamous cell carcinoma on the vocal cord in a patient with advanced dementia, no surviving relatives, and no advance directives?
  • Should you inform your patient's employer that the patient insists on continuing to work despite being told that her ability to do her job safely will be compromised by the opiates she is receiving for pain?

Because arriving at a resolution to an ethical dilemma is often facilitated by discussion with others and consideration of the situation from a variety of perspectives, readers are encouraged to comment on the case discussions on the Cancer Network. Visitors to the site are already adding their thoughts on the feature's first cases.

Readers are also invited to submit cases. Names and identifying details will be changed in any case selected for use in the feature so as to ensure protection of privacy.

About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, MusculoskeletalNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect – which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit http://www.UBMMedicaUS.com           

Media contact:
Jason J. Golden
Content Marketing Manager
203-523-7040
jason.golden@ubm.com


'/>"/>
SOURCE UBM Medica US
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
2. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
3. Champions Oncology Reports Resignation Of Director
4. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
5. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
6. Radiation Therapy in Oncology Drug Pipeline Update 2012
7. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
8. Schulman Associates IRB offers oncology-focused review board
9. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
10. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
11. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... and Gulf Coast Regional Blood Center to host a blood ... Law family has had 3 members that needed blood products ... is partnering with Gulf Coast Regional Blood Center of ... supplies are running low. Gulf Coast Regional Blood Center,s inventory is ... is why the blood center reached out to Mostyn Law ...
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/15/2017)... N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator ... rumored to be in the beginning stages of an IPO. ... on epilepsy medications with the average cost of a prescription epilepsy drug ... ... Another staggering figure is the fact ...
Breaking Medicine Technology:
(Date:8/16/2017)... NJ (PRWEB) , ... August 16, 2017 , ... With low back pain afflicting 8 ... know what causes its kissing cousin – upper back pain. But this equally vexing condition ... treatment options, according to Kaixuan Liu, MD, PhD , founder and president of Atlantic ...
(Date:8/16/2017)... ... August 16, 2017 , ... “Mom, God's Got This: Jamie's Story” is the creation ... with the Lord and has an insatiable appetite for God’s Word. , “I froze between ... free gifts retrieved from packages of oatmeal. I have one to this day on proud ...
(Date:8/15/2017)... Buffalo, NY (PRWEB) , ... August 15, 2017 , ... ... as maintenance treatment for multiple myeloma has been completed, with the team’s findings now ... Philip L. McCarthy, MD , Director of the Blood and Marrow Transplant Program at ...
(Date:8/15/2017)... ... 15, 2017 , ... Horizon Goodwill is honored to receive ... overwhelmed with gratitude for the very generous donation from BB&T. Our mission is ... get a job and keep it. This donation will go a long way ...
(Date:8/15/2017)... ... August 15, 2017 , ... ... to announce the 19th Annual V Foundation Wine Celebration raised nearly $9 million ... more than $7 million in “Fund-A-Need” donations to support the study of BRCA ...
Breaking Medicine News(10 mins):